On a cold night in the Gobi, a tourist van, limping on three tires and a steel rim, bounced up to a ger, the circular tent of the desert nomads.
After peering into the tent, the three young tourists asked the herdsmen inside for help. The men grouchily gave them a choice: watch the last half of a South Korean soap opera on television, or wait it out under the stars.
"They were just too busy to notice us," Khorolsuren Byambasuren, the tour guide, said here, still miffed at the memory of her mid-September mishap. "They waited until midnight, when Min Sung-yong happily met Kim In-ha, at the last part of Intrigues of the Life. Then the guys enthusiastically helped us, and we were on our way to the tourist camp at 3am."
Mongolia's ancient hospitality takes a holiday during the time slot for dubbed South Korean soap operas. With Mongolia's two main television channels showing South Korean movies daily, a giant Do Not Disturb sign goes up every evening across this sparsely populated land.
Mongolians and Koreans are ethnically related peoples cut off by centuries of history. In the 13th century, Mongolians swept across China and down the Korean Peninsula, and were on the brink of invading Japan until several naval disasters changed their minds.
Mongolia's occupation of Korea left linguistic affinities, shared genes and wild horse herds, known to this day as Mongolians, on the South Korean island of Cheju, the staging base for the frustrated invasion of Japan.
Today's bonds reflect, to some degree, the solidarity of two small nations living on the edges of a rising China. Commercially, Mongolia is an outpost for Korean business. On an ethnic level, Koreans and Mongolians are like fraternal twins.
Advertising banners here implore "UB"girls to try a cosmetics line from Seoul, Ulan Bator's new style maker. For ad campaigns in Mongolia, South Korean companies do not bother to reshoot with local models.
"It works -- our features are that similar," Byambasuren said over lunch at a sidewalk cafe.
Kim Sung-chul, a South Korean pastor who has been here three years, said, "We look the same; our skin is the same; our grammar structure is the same."
Since 1999, the year Kim Dae-jung, then South Korea's president, flew here, the Ulan Bator-Seoul route has been one of the busiest for Korean Air and Mongolian Airlines.
Remittances from Mongolians working in South Korea have become an important source of income to this nation of 2.5 million. With 20,000 Mongolians in South Korea, the country now has more Mongolians than Japan, Europe and the US combined.
While some Mongolians say they are put off by a Korean arrogance, many Koreans say the advantages are there for both sides.
"After two years, Koreans can speak Mongolian," said Kim Wan-jin, a translator.
"But it is even easier for Mongolian people to learn Korean," Kim said.
The COVID-19 variant discovered in South Africa can “break through” Pfizer-BioNTech’s COVID-19 vaccine to some extent, a real-world data study released on Saturday found, although its prevalence in the country is low and the research has not been peer reviewed. The study in Israel compared almost 400 people who had tested positive for COVID-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated people with the disease. It matched age and gender, among other characteristics. The South African variant, B.1.351, was found to make up about 1 percent of all the COVID-19
RARE ADMISSION: A top Chinese expert was the first to publicly address the efficacy of the nation’s vaccines as it aims to inoculate 40 percent of its population by June China is considering mixing different COVID-19 vaccines to improve the relatively low efficacy of its existing options, a top health expert told a conference in Chengdu on Saturday. Authorities have to “consider ways to solve the issue that efficacy rates of existing vaccines are not high,” Chinese media outlet The Paper reported, citing Chinese Center for Disease Control and Prevention Director Gao Fu (高福). His comments mark the first time a top Chinese expert has publicly alluded to the relatively low efficacy of the country’s vaccines, as China forges ahead in its mass vaccination campaign and exports its jabs around the world. China
The Australian government yesterday said that it had decided against buying the single-dose Johnson & Johnson (J&J) COVID-19 vaccine and identified a second case of a rare blood clot likely linked to the AstraZeneca shot. The Australian government had been in talks with the New Jersey-based pharmaceutical giant, which had asked the Australian Therapeutic Goods Administration for provisional registration. However, Australian Minister of Health Greg Hunt ruled out a J&J contract, because its vaccine was similar to the AstraZeneca product, which Australia had already contracted for 53.8 million doses. Hunt said the government was following the advice of Australia’s scientific and technical advisory
The Indonesian government has said it is satisfied with the effectiveness of the Chinese COVID-19 vaccine it has been using, after China’s top disease control official said that current vaccines offer low protection against the novel coronavirus. Siti Nadia Tarmizi, a spokesperson for Indonesia’s COVID-19 vaccine program, on Monday said the WHO had found that the Chinese vaccines had met requirements by being more than 50 percent effective. Clinical trials in Indonesia for the vaccine from Chinese drugmaker Sinovac showed that it was 65 percent effective, she said. “It means ... the ability to form antibodies in our bodies is still very
RSS